Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03810742
Brief Title: Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

First Submitted : December 21, 2018
First Submitted that Met QC Criteria : January 17, 2019
First Posted : January 22, 2019

Last Update Submitted that Met QC Criteria : September 16, 2021
Last Update Posted : September 17, 2021